Ravikanti Nikhita, Okut Hayrettin, Keomany Jennifer, Ablah Elizabeth, Bradley Kent
University of Kansas School of Medicine-Wichita, Wichita, KS.
Office of Research.
Kans J Med. 2022 Oct 24;15(3):373-379. doi: 10.17161/kjm.vol15.18246. eCollection 2022.
There have been many efforts to combat the United States opioid crisis that has been occurring for the past two decades, specifically with postpartum patients that often were prescribed opioids. Prior studies described how accounting for usage of inpatient opioids on the day prior to discharge had an impact on how much discharge opioids were prescribed on the day of discharge. These studies provided a guideline to use the inpatient opioid amount from the day before discharge to determine discharge opioid quantity and minimize how much was being prescribed. In July 2018, the American College of Obstetrics and Gynecologists (ACOG) published Committee Opinion 742, guidelines for obstetricians-gynecologists about post-partum pain management. Prescription pain medications (including opioids, if necessary) require a shared decision-making approach between the physician and patient to determine the medication type and quantity. This study aimed to determine if there were differences in prescribing practices based on the specific post-operative day that opioid prescriptions were written, and if there were differences in the prescribing practices for cesarean deliveries following the publication of ACOG Committee Opinion 742.
This retrospective chart review included patients who had a live cesarean birth at one rural Midwest facility anytime between July 1, 2017 and February 28, 2021. This study excluded those with chorioamnionitis and those discharged after more than four days. Opioid amounts were converted to oral morphine milligram equivalents (MME) for comparison, and total MME was calculated for each prescription. Patients were stratified into two groups based on the day that their discharge opioid medication prescriptions were written (i.e., a day prior to discharge or the day of discharge). Patients were also stratified based on date of delivery, before or after the publication of ACOG Committee Opinion 742.
Of 411 cesarean patients, 93.9% (n = 386) had opioids prescribed at discharge, 86% (n = 330) of whom received a prescription written on the day of discharge. There was no difference in the quantity of MMEs, doses per day, or dosage from discharge prescriptions between those written on the day of discharge and those written on a prior day. Patients whose deliveries occurred after the publication of ACOG Committee Opinion 742 (63.9%, n = 263) received discharge prescriptions with fewer average MMEs (159.53 ± 61.64) than those whose deliveries occurred before the publication (36%, n = 148; 187.35 ± 53.42; χ (1, N = 411) = 17.71; p < 0.001), and they were prescribed fewer doses per day.
After cesarean sections, the specific post-operative day did not seem to impact the prescribing trends as there were no differences in MMEs, doses per day, or dosage between prescriptions that were written on the day of discharge and before the day of discharge. Patients whose deliveries occurred after the publication of ACOG Committee Opinion 742 received discharge prescriptions with fewer MMEs, fewer doses per day, and the same dosage than those whose deliveries occurred before the publication, reflecting the overall national trend of decreasing prescription opioids over these years.
在过去二十年里,人们为应对美国的阿片类药物危机做出了诸多努力,尤其是针对经常被开具阿片类药物的产后患者。先前的研究描述了考虑出院前一天住院期间阿片类药物的使用情况如何影响出院当天开具的出院阿片类药物的剂量。这些研究提供了一个指导方针,即利用出院前一天的住院阿片类药物用量来确定出院时阿片类药物的数量,并尽量减少开具的剂量。2018年7月,美国妇产科医师学会(ACOG)发布了第742号委员会意见,即关于妇产科医生产后疼痛管理的指南。处方止痛药物(如有必要,包括阿片类药物)需要医生和患者共同决策,以确定药物类型和数量。本研究旨在确定根据开具阿片类药物处方的具体术后日期,处方做法是否存在差异,以及在ACOG委员会意见742发布后,剖宫产的处方做法是否存在差异。
这项回顾性病历审查纳入了2017年7月1日至2021年2月28日期间在中西部一家农村医疗机构进行活产剖宫产的患者。本研究排除了患有绒毛膜羊膜炎的患者以及出院超过四天的患者。为便于比较,将阿片类药物用量换算为口服吗啡毫克当量(MME),并计算每张处方的总MME。根据出院阿片类药物处方开具的日期(即出院前一天或出院当天),将患者分为两组。患者还根据分娩日期进行分层,分为ACOG委员会意见742发布之前或之后。
在411例剖宫产患者中,93.9%(n = 386)在出院时开具了阿片类药物,其中86%(n = 330)的患者在出院当天收到了处方。出院当天开具的处方与前一天开具的处方相比,MME数量、每日剂量或出院处方剂量均无差异。在ACOG委员会意见742发布后分娩的患者(63.9%,n = 263),其出院处方的平均MME(159.53±61.64)少于在该意见发布前分娩的患者(36%,n = 148;187.35±53.42;χ(1, N = 411) = 17.71;p < 0.001),且每日开具的剂量也较少。
剖宫产术后,具体的术后日期似乎并未影响处方趋势,因为出院当天开具的处方与出院前一天开具的处方在MME、每日剂量或剂量方面均无差异。在ACOG委员会意见742发布后分娩的患者,其出院处方的MME较少、每日剂量较少,且剂量与在该意见发布前分娩的患者相同,这反映了这些年来全国范围内处方阿片类药物减少的总体趋势。